Representative before the EPO

Employment test 501 - 1000 employees
Company dna marks and clerk llp
operating since 1887
Headquarter in London and 16 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

Sheila Jane Wallace has worked on the following 122 EPO patent applications which have been published in the last five years:

EP11814558

PROCESS FOR PREPARING COMPOUND BY NOVEL SANDMEYER-LIKE REACTION USING NITROXIDE RADICAL COMPOUND AS REACTION CATALYST

IPC classification:
A61P 7/02, A61P 43/00, C07B 61/00, C07C 201/12, C07C 205/12, C07C 253/30, C07C 255/50, C07D 513/04, A61K 31/444
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
The patent has been granted
EP11819897

CRYSTAL OF TRICYCLIC PYRAZOLOPYRIMIDINE DERIVATIVE

IPC classification:
A61P 35/00, C07D 495/16, A61K 31/519
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
APPLICATION WITHDRAWN
EP11819896

FREE CRYSTAL OF TRICYCLIC PYRAZOLOPYRIMIDINE DERIVATIVE

IPC classification:
A61P 35/00, C07D 495/16, A61K 31/519
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11775045

[5,6]HETEROCYCLIC COMPOUND

IPC classification:
A61P 5/18, A61P 19/08, A61P 19/10, C07D 235/06, C07D 401/04, C07D 403/04, C07D 405/12, C07D 405/14, C07D 417/04, C07D 471/04, A61K 31/4184, A61K 31/4188, A61K 31/427, A61K 31/437, A61K 31/4439, A61K 31/444, A61K 31/454, A61K 31/4545, A61K 31/496, A61K 31/506, A61K 31/5377
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
APPLICATION WITHDRAWN
EP13172342

System and method of administering a pharmaceutical gas to a patient

IPC classification:
A61M 16/12
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP11778330

BARRIER FILM WITH RECLAIMED METALIZED POLYESTER

IPC classification:
B29B 17/00, B32B 15/08, B32B 17/10, B32B 27/36, C08J 11/04, C08L 67/02, A23L 1/01
Applicant:
Toray Plastics America Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12709150

DIETHYLSTILBESTROL DOSAGE FORM AND USE FOR THE TREATMENT OF PROSTATE OR BREAST CANCER

IPC classification:
A61P 35/00, A61K 9/00, A61K 31/56
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
ABG Patentes SL
Status:
GRANT OF PATENT INTENDED
EP12755073

DISPIROPYRROLIDINE DERIVATIVE

IPC classification:
A61P 35/00, A61P 35/02, A61P 43/00, C07D 471/20, C07D 487/10, C07D 519/00, A61K 31/407, A61K 31/437, A61K 31/4439, A61K 31/506, A61K 31/5377
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12790231

CLOZAPINE IMMUNOASSAY

IPC classification:
A61P 25/18, C12Q 1/00
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12727936

HETEROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS

IPC classification:
A61P 19/00, A61P 29/00, A61P 35/00, A61P 37/00, C07D 471/04, A61K 31/437
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14150954

Pharmaceutical compositions and methods for producing low impurity concentrations of the same

IPC classification:
A61P 9/12, A61K 31/519
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12820526

N-HETERO-RING-SUBSTITUTED AMIDE DERIVATIVE

IPC classification:
A61P 3/04, A61P 3/10, A61P 5/48, A61P 43/00, C07D 413/12, A61K 31/4245
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
PATENT GRANTED
EP12820267

OPTICALLY CLEAR BIAXIALLY ORIENTED POLYESTER FILM WITH ANTI-IRIDESCENT PRIMER LAYER

IPC classification:
B32B 37/00
Applicant:
Toray Plastics America Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12735415

HCV GENOTYPE 3 REPLICONS

IPC classification:
C07K 14/005, C12N 15/86, G01N 33/569
Applicant:
Gilead Sciences Inc
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12735402

FUSED BENZOXAZEPINONES AS ION CHANNEL MODULATORS

IPC classification:
C07D 243/24, C07D 267/14, C07D 291/08, C07D 403/06, C07D 413/06, C07D 413/12, C07D 413/14, C07D 419/06, C07D 471/04, C07D 487/04, C07D 498/04, A61K 31/5513, A61K 31/553, A61K 31/554
Applicant:
Gilead Sciences Inc
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12737664

HCV GENOTYPE 4 REPLICONS

IPC classification:
C07K 14/005, C12N 15/86, G01N 33/569
Applicant:
Gilead Sciences Inc
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12735400

OXAZEPINES AS ION CHANNEL MODULATORS

IPC classification:
C07D 267/14, C07D 413/04, C07D 413/12, C07D 413/14, C07D 498/04, A61K 31/553
Applicant:
Gilead Sciences Inc
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12738352

THIOPHEN-2-CARBOXYLIC ACID DERIVATIVES USEFUL AS INHIBITORS OF FLAVIVIRIDAE VIRUSES

IPC classification:
A61P 31/14, C07D 333/40, A61K 31/381
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Christopher William Bond, Forresters IP LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12722595

FUSED HETEROCYCLIC COMPOUNDS AS SODIUM CHANNEL MODULATORS

IPC classification:
C07D 237/32, C07D 253/08, C07D 265/22, C07D 401/04, C07D 401/06, C07D 401/12, C07D 403/04, C07D 403/06, C07D 403/08, C07D 403/12, C07D 403/14, C07D 413/06, C07D 413/12, C07D 413/14, C07D 417/06
Applicant:
Gilead Sciences Inc
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12715516

USE OF A2B ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING HEART FAILURE AND ARRHYTHMIA IN POST-MYOCARDIAL INFARCTION PATIENTS

IPC classification:
A61P 9/00, A61P 9/04, A61P 9/10, A61K 9/00, A61K 31/40, A61K 31/403, A61K 31/522, A61K 45/06
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED
EP11794350

COMPOUNDS

IPC classification:
A61P 31/14, C07H 19/06, C07H 19/10, C07H 19/16, C07H 19/20, C07H 23/00, A61K 31/7068, A61K 31/7072, A61K 31/7076
Applicant:
Gilead Pharmasset LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Ross Thomson Walker, Forresters IP LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
EXAMINATION IN PROGRESS
EP11805298

COMBINATIONS FOR TREATING HCV

IPC classification:
A61P 31/12, A61K 31/381, A61K 31/40, A61K 31/401, A61K 31/4025, A61K 31/407, A61K 31/4178, A61K 31/4188, A61K 31/4353, A61K 31/4436, A61K 31/662, A61K 31/7056
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
EXAMINATION REQUESTED
EP11714467

PURINE NUCLEOSIDE PHOSPHORAMIDATE

IPC classification:
A61P 31/14, C07H 19/20, A61K 31/7076
Applicant:
Gilead Pharmasset LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Christopher William Bond, Forresters IP LLP
Agent:
Schwarz & Partner
Status:
EXAMINATION IN PROGRESS
EP11700988

INHIBITORS OF FLAVIVIRIDAE VIRUSES

IPC classification:
A61P 31/00, C07D 409/12, A61K 31/381, A61K 31/4436
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED
EP12769522

ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION

IPC classification:
C07D 311/36, C07D 405/06, A61K 31/352, A61K 31/397, A61K 31/4178
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13182837

3',5'-cyclic nucleoside phosphate analogues

IPC classification:
A61P 31/14, C07H 19/167, C07H 19/20, C07H 19/213, A61K 31/7076
Applicant:
Gilead Pharmasset LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Christopher William Bond, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12769826

SODIUM CHANNEL BLOCKERS REDUCE GLUCAGON SECRETION

IPC classification:
A61P 3/10, A61K 31/4196, A61K 31/495, A61K 45/06
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12789648

SOLID FORMS OF A PHARMACEUTICALLY ACTIVE SUBSTANCE

IPC classification:
A61P 35/00, C07D 471/04, A61K 31/437
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12745360

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

IPC classification:
C07D 471/04, A61K 31/437, A61K 31/506, A61K 31/5377
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12848361

ACC INHIBITORS AND USES THEREOF

IPC classification:
A61K 31/38, A61K 31/519
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Holger Tostmann, Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB
Status:
EXAMINATION IN PROGRESS
EP12787261

METHODS AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUS

IPC classification:
A61P 31/14, A61K 31/4196, A61K 31/513
Applicant:
Gilead Pharmasset LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12795307

COMPOSITIONS AND METHODS FOR TREATING HEPATITIS C VIRUS

IPC classification:
A61P 31/14, A61K 9/20, A61K 31/4196, A61K 31/513
Applicant:
Gilead Pharmasset LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14151876

Nucleoside phosphoramidate prodrugs

IPC classification:
A61P 31/00, C07H 19/20, A61K 31/7072
Applicant:
Gilead Pharmasset LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12808657

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL INFECTIONS AND DISORDERS

IPC classification:
A61P 31/00, A61P 33/00, A61P 35/00, A61P 37/00, A61K 31/4985
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14169060

Nucleoside phosphoramidate prodrugs

IPC classification:
A61P 31/00, C07H 19/20, A61K 31/7072
Applicant:
Gilead Pharmasset LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13194605

methods for the preparation of thieno[3,4-d]pyrimidin-7-yl ribosides

IPC classification:
C07D 495/04
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED
EP11715792

2' -FLUORO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT

IPC classification:
C07D 487/04, A61K 31/41
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14179253

Dihydrochloride salt of a tricyclic pyrazolopyrimidine derivative

IPC classification:
A61P 35/00, C07D 495/16, A61K 31/519
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13743985

PYRIDONE DERIVATIVE

IPC classification:
A61P 35/00, A61P 43/00, C07D 213/82, C07D 401/14, C07D 405/14, C07D 413/14, C07D 471/08, A61K 31/444, A61K 31/4545, A61K 31/501, A61K 31/5377
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
PATENT GRANTED
EP12735394

COMPOUNDS FOR THE TREATMENT OF ADDICTION

IPC classification:
A61P 25/30, A61P 25/32, A61P 25/34, A61P 25/36, C07D 213/64, A61K 31/4418
Applicant:
Gilead Sciences Inc
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14158708

Intermediates for the preparation of modulators of toll-like receptors

IPC classification:
C07D 403/12
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
PATENT GRANTED
EP12789833

GEMCITABINE IMMUNOASSAY

IPC classification:
C07H 19/06, C07K 16/44, G01N 33/53, G01N 33/543
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14179593

Nucleoside phosphoramidate prodrugs

IPC classification:
A61P 31/00, C07H 19/20, A61K 31/7072
Applicant:
Gilead Pharmasset LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP14183494

Therapeutic compositions comprising rilpivirin hcl and tenofovir disoproxil fumarate

IPC classification:
A61P 31/18, A61K 9/20, A61K 31/505, A61K 31/513, A61K 31/675
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14179358

Nucleoside phosphoramidate prodrugs

IPC classification:
A61P 31/00, C07H 19/20, A61K 31/7072
Applicant:
Gilead Pharmasset LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13714152

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

IPC classification:
A61P 19/08, A61P 19/10, A61P 25/00, A61P 25/28, A61P 25/30, A61P 35/00, A61K 31/436, A61K 31/437, A61K 31/4545, A61K 31/506, A61K 45/06
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14161300

Method of treating atrial fibrillation

IPC classification:
A61P 9/06, A61K 31/343, A61K 31/495
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13769439

(2-HETEROARYLAMINO)SUCCINIC ACID DERIVATIVE

IPC classification:
A61P 7/06, A61P 43/00, C07D 213/75, C07D 213/82, C07D 239/47, C07D 401/12, C07D 405/14, A61K 31/44, A61K 31/506, A61K 31/513
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13768519

4-ALKANOYLAMINO-3-PYRAZOLONE DERIVATIVE

IPC classification:
A61P 7/06, A61P 43/00, C07D 401/04, C07D 401/14, C07D 403/04, A61K 31/4439, A61K 31/444, A61K 31/506, A61K 31/5377
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP14163247

Stereoselective synthesis of phosphorus containing actives

IPC classification:
A61P 31/14, C07F 7/18, C07F 9/24, C07F 9/655, C07F 9/6558, C07F 9/6561, C07H 19/04, C07H 19/044, C07H 19/052, C07H 19/06, C07H 19/10, C07H 19/20, C07H 19/207, C07H 19/24, A61K 31/7076
Applicant:
Gilead Pharmasset LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP14171097

2',4'-substituted nucleosides as antiviral agents

IPC classification:
A61P 31/12, C07H 19/06, C07H 19/16, A61K 31/7068, A61K 31/7076
Applicant:
Gilead Pharmasset LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13801320

IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVE AS KINASE INHIBITOR

IPC classification:
A61P 35/00, A61P 35/02, A61P 43/00, C07D 487/04, A61K 31/5025
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13725159

PROCESS FOR THE PREPARATION OF 2-DEOXY-2-FLUORO-2-METHYL-D-RIBOFURANOSYL NUCLEOSIDE COMPOUNDS

IPC classification:
A61P 31/12, C07H 1/00, C07H 19/06
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Gilead Pharmasset LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Beat Rauber, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13730439

MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES

IPC classification:
A61P 31/14, C07D 487/08, C07D 498/08, C07D 498/18, C07K 5/062
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13729240

MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES

IPC classification:
A61P 31/14, C07D 487/08, C07D 498/08, C07D 498/18, C07D 498/22, A61K 31/504
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13731203

MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES

IPC classification:
A61P 31/12, A61P 35/00, C07D 487/18, C07D 498/18, A61K 31/504
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
PATENT GRANTED
EP13727790

SYNTHESIS OF PYRROLO [2, 3 - B]PYRIDINES

IPC classification:
C07D 471/04
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP11726037

RANOLAZINE FOR USE FOR THE TREATMENT OF PULMONARY HYPERTENSION

IPC classification:
A61P 9/00, A61K 31/495
Applicant:
Gilead Sciences Inc
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13835941

CRYSTAL OF DISPIROPYRROLIDINE DERIVATIVE

IPC classification:
A61P 35/00, C07D 487/10, A61K 31/4439
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
The patent has been granted
EP13854871

ROOM-TEMPERATURE-CURABLE POLYORGANOSILOXANE COMPOSITION

IPC classification:
C08K 3/00, C08K 5/5415, C08K 5/544, C08L 83/06
Applicant:
Momentive Performance Materials Japan LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
APPLICATION WITHDRAWN
EP13858125

NON-IRIDESCENT FILM WITH POLYMERIC PARTICLES IN PRIMER LAYER

IPC classification:
B32B 7/02
Applicant:
Toray Plastics America Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
APPLICATION WITHDRAWN
EP15165114

NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS

IPC classification:
A61P 31/00, C07H 19/20, A61K 31/7072
Applicant:
Gilead Pharmasset LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15151030

Apoptosis signal-regulating kinase inhibitors

IPC classification:
A61P 9/00, A61P 25/28, A61P 29/00, A61P 37/00, C07D 401/12, C07D 401/14, C07D 407/14, C07D 413/14, C07D 471/04, C07D 491/048, A61K 31/437, A61K 31/4439, A61K 31/444, A61K 31/497, A61K 31/506
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP15155479

1' -substituted carba-nucleoside analogs for antiviral treatment

IPC classification:
A61P 31/12, C07D 487/04, C07H 19/23, A61K 31/395, A61K 31/41, A61K 31/4188, A61K 31/7052
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14700590

PROCESS FOR THE PREPARATION OF A FLUOROLACTON DERIVATIVE

IPC classification:
C07D 263/26, C07D 307/33, C07D 413/06
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Beat Rauber, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14704502

COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS

IPC classification:
A61K 9/16, A61K 9/20, A61K 31/501, A61K 31/513
Applicant:
Gilead Pharmasset LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP15171526

PROPANE-I-SULFONIC ACID {3- [5- (4- CHLORO-PHENYL) -1H-PYRROLO [2, 3-B} PYRIDINE-3-CARBONYL] -2, 4-DIFLUORO-PHENYL} -AMIDE COMPOSITIONS AND USES THEREOF

IPC classification:
A61P 35/00, C07D 471/04, A61K 31/437
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15179426

SILICONE COMPOSITION FOR SEALING LIGHT EMITTING ELEMENT, AND LIGHT EMITTING DEVICE

IPC classification:
C08L 83/04, H01L 23/29
Applicant:
Momentive Performance Materials Japan LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP11756704

RISPERIDONE IMMUNOASSAY

IPC classification:
G01N 33/94, A01N 43/90, A61K 31/519
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14722892

MULTI-LAYER ADDITIVE TEXTURE LAMINATES AND METHODS

IPC classification:
B41M 3/00, B41M 3/06
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14715529

HETEROCYCLIC COMPOUNDS AND USES THEREOF

IPC classification:
A61P 35/00, C07D 471/04, A61K 31/437
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14729114

BENZIMIDAZOLONE DERIVATIVES AS BROMODOMAIN INHIBITORS

IPC classification:
A61P 35/00, C07D 413/04, C07D 413/14, C07D 417/14, A61K 31/42
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
PATENT GRANTED
EP11730524

USE OF A2B ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING PULMONARY HYPERTENSION

IPC classification:
A61P 9/12, A61P 11/00, A61K 31/00, A61K 31/522
Applicant:
Gilead Sciences Inc
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14729182

BENZIMIDAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS

IPC classification:
A61P 35/00, C07D 413/04, C07D 413/14, C07D 417/14, A61K 31/422
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14794603

ACC INHIBITORS AND USES THEREOF

IPC classification:
C07D 495/04, A61K 31/38
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Holger Tostmann, Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB
Status:
GRANT OF PATENT INTENDED
EP14795147

ACC INHIBITORS AND USES THEREOF

IPC classification:
A61K 31/4375, A61K 31/517
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Holger Tostmann, Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB
Status:
GRANT OF PATENT INTENDED
EP14795076

ACC INHIBITORS AND USES THEREOF

IPC classification:
A61K 31/497
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Holger Tostmann, Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB
Status:
GRANT OF PATENT INTENDED
EP14794757

ACC INHIBITORS AND USES THEREOF

IPC classification:
A61K 31/4375, A61K 31/517
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Holger Tostmann, Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB
Status:
GRANT OF PATENT INTENDED
EP15177723

OXAZEPINES AS ION CHANNEL MODULATORS

IPC classification:
A61P 9/10, C07D 267/14, C07D 413/04, C07D 413/12, C07D 413/14, C07D 498/04, A61K 31/553
Applicant:
Gilead Sciences Inc
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
The patent has been granted
EP11743400

METHODS FOR THE PREPARATION OF DIASTEROMERICALLY PURE PHOSPHORAMIDATE PRODRUGS

IPC classification:
C07D 309/10, C07H 1/00, C07H 1/06, C07H 19/02, C07H 19/10, C07H 19/20
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Schwarz & Partner
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11791161

THERAPEUTIC COMPOSITIONS COMPRISING RILPIVIRIN HCL AND TENOVOFIR DISOPROXIL FUMARATE

IPC classification:
A61P 31/18, A61K 9/20, A61K 31/505, A61K 31/513, A61K 31/675
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Huw Hallybone, Carpmaels & Ransford LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
PATENT GRANTED
EP10798436

METHOD OF TREATING ATRIAL FIBRILLATION

IPC classification:
A61P 9/06, A61K 31/343, A61K 31/495
Applicant:
Gilead Sciences Inc
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14733877

COMPOUNDS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

IPC classification:
C07D 213/75, C07D 417/04, C07D 471/04, C07D 487/04, A61K 31/519
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP11734220

APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS

IPC classification:
A61P 9/00, A61P 29/00, A61P 37/00, C07D 409/14, C07D 417/14, A61K 31/4196, A61K 31/427, A61K 31/4427
Applicant:
Gilead Sciences Inc
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14822899

ADHESIVENESS-IMPARTING AGENT, ADHESIVE POLYORGANOSILOXANE COMPOSITION, AND OPTICAL SEMICONDUCTOR DEVICE

IPC classification:
C08G 59/02, C08G 77/14, C08G 77/20, C08L 83/05, C08L 83/06, C08L 83/07
Applicant:
Momentive Performance Materials Japan LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12798525

CONDENSED IMIDAZOLYLIMIDAZOLES AS ANTIVIRAL COMPOUNDS

IPC classification:
C07D 491/052, A61K 31/4188
Applicant:
Gilead Pharmasset LLC
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14827046

MEMBRANE SEPARATION OF OLEFIN AND PARAFFIN MIXTURES

IPC classification:
B01D 15/00, B01D 53/22, C08F 14/16
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP11724336

HETEROCYCLIC FLAVIVIRIDAE VIRUS INHIBITORS

IPC classification:
A61P 31/14, C07D 487/04, A61K 31/5025, A61K 31/519
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11732540

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

IPC classification:
A61P 3/10, A61P 9/00, C07D 471/04, A61K 31/437
Applicant:
Gilead Sciences Inc
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11833207

CLEVIDIPINE EMULSION FORMULATIONS CONTAINING ANTIMICROBIAL AGENTS

IPC classification:
A61K 9/107, A61K 31/4418, A61K 47/10, A61K 47/12, A61K 47/14, A61K 47/18, A61K 47/24, A61K 47/44
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
PATENT GRANTED
EP13152340

Modified fluorinated nucleoside analogues

IPC classification:
A61P 31/14, C07H 19/06, C07H 19/10, A61K 31/7068
Applicant:
Gilead Pharmasset LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Ross Thomson Walker, Forresters IP LLP
Status:
PATENT GRANTED
EP10854244

RELEASABLE METALIZED EMBOSSED TRANSFER FILM

IPC classification:
G03H 1/00
Applicant:
Toray Plastics America Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
PATENT GRANTED
EP16150080

RELEASABLE POLYESTER HIGH GLOSS METAL TRANSFER FILM

IPC classification:
B32B 7/06, B32B 7/12, B32B 15/12, B32B 27/08, B32B 27/18, B32B 27/20, B32B 27/36, B32B 37/02
Applicant:
Toray Plastics America Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14842419

METHOD FOR PRODUCING SPIROOXINDOLE DERIVATIVE

IPC classification:
B01J 23/72, B01J 27/122, B01J 31/02, B01J 31/04, B01J 31/22, C07B 53/00, C07B 61/00, C07D 487/10, C07D 491/20
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12192594

2',4'-substituted nucleosides as antiviral agents

IPC classification:
A61P 31/12, C07H 19/06, C07H 19/16, A61K 31/7068, A61K 31/7076
Applicant:
Gilead Pharmasset LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Ross Thomson Walker, Forresters IP LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14766297

BIARYL ACETAMIDE COMPOUNDS AND METHODS OF USE THEREOF

IPC classification:
A61P 35/00, C07D 403/12, C07D 413/12, C07D 413/14, C07D 487/04, C07D 495/04, C07D 498/14, A61K 31/421
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP10858264

BARRIER COATING COMPOSITION WITH ORGANIC PARTICLES

IPC classification:
B05D 7/00, B05D 7/04, B32B 27/08, B32B 27/30, C08J 7/04, C08K 9/10, C08L 101/00, C09D 129/04
Applicant:
Toray Plastics America Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
PATENT GRANTED
EP11805697

MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES

IPC classification:
A61P 31/14, C07D 487/08, C07D 498/08, C07D 498/18, A61K 31/504
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14799284

HYDROPHILIC/HYDROPHOBIC AQUEOUS POLYMER EMULSIONS AND PRODUCTS AND METHODS RELATING THERETO

IPC classification:
C08F 2/22, C08F 220/20, C09D 133/06
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14796977

HYDROPHILIC/HYDROPHOBIC AQUEOUS POLYMER EMULSIONS AND PRODUCTS AND METHODS RELATING THERETO

IPC classification:
C08J 7/12
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP11753786

LENALIDOMIDE AND THALIDOMIDE IMMUNOASSAYS

IPC classification:
G01N 33/94, A01N 43/38, A61K 31/40
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11800739

METHOD FOR SCREENING FOR S1P LYASE INHIBITOR USING CULTURED CELL

IPC classification:
C12Q 1/02, C12Q 1/68, G01N 33/15, G01N 33/50, G01N 33/92
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14862562

TABLET

IPC classification:
A61K 9/20, A61K 47/10, A61K 47/12, A61K 47/32, A61K 47/36, A61K 47/38
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP11701588

INHIBITORS OF FLAVIVIRIDAE VIRUSES

IPC classification:
A61P 31/00, C07D 409/12, C07D 409/14, C07D 493/04, A61K 31/381, A61K 31/4436
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14875467

ROOM-TEMPERATURE-CURABLE POLYORGANOSILOXANE COMPOSITION AND ELECTRIC/ELECTRONIC DEVICE

IPC classification:
C08K 5/56, C08L 83/04, C08L 83/06, C09D 183/06
Applicant:
Momentive Performance Materials Japan LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP10763902

INHIBITORS OF FLAVIVIRIDAE VIRUSES

IPC classification:
A61P 31/12, C07F 9/30, C07F 9/32, C07F 9/40, C07F 9/6568, A61K 31/662
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Agent:
Reitstötter Kinzebach & Partner GbR
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15752746

METHOD FOR PRODUCING INHIBITOR OF ACTIVATED BLOOD COAGULATION FACTOR X (FXA)

IPC classification:
A61P 7/02, C07B 61/00, C07D 513/04, A61K 31/444
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP16184567

ORGANIC PHOTOVOLTAIC DEVICES

IPC classification:
H01L 51/42
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
APPLICATION PUBLISHED
EP15796913

CANCER STEM CELL PROLIFERATION INHIBITOR

IPC classification:
A61P 35/00, A61P 43/00, C12N 5/095, A61K 31/192, A61K 31/196, A61K 45/00
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15728994

CHITOSAN AND POLYETHYLENE GLYCOL COPOLYMERS AND METHODS AND DEVICES FOR USING SAME FOR SEALING A VASCULAR PUNCTURE

IPC classification:
A61L 31/04, A61L 31/06, A61L 31/14
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15747600

THIN-FILM COMPOSITE RETRIEVABLE ENDOVASCULAR DEVICES AND METHOD OF USE

IPC classification:
A61F 2/01, A61F 2/91, A61F 2/962
Applicant:
Cordis Corporation
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15730608

IMPROVED ENDOPROSTHESIS ANCHORING AND SEALING

IPC classification:
A61F 2/07, A61F 2/848
Applicant:
Cordis Corporation
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15748307

TRICYCLIC BENZOXABOROLES AS ANTIBACTERIAL AGENTS

IPC classification:
A61P 31/04, C07F 5/02, A61K 31/69
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15818440

PYRIDONE DERIVATIVE HAVING TETRAHYDROPYRANYL METHYL GROUP

IPC classification:
A61P 35/00, A61P 35/02, A61P 35/04, A61P 43/00, C07D 405/14, C07D 409/14, A61K 31/444, A61K 31/496, A61K 31/497, A61K 31/501, A61K 31/506, A61K 31/5377
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15744455

FOAM LAMINATE DRESSING

IPC classification:
A61F 13/00
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15753258

METHOD FOR CONTROLLING NUTRIENT DEPLETION FROM AGRICULTURAL SOILS

IPC classification:
C05F 11/00, C05F 11/02
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP15771345

HETEROCYCLIC COMPOUNDS AND USES THEREOF

IPC classification:
A61P 35/00, C07D 413/14, C07D 471/04, C07D 487/04, A61K 31/538
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
Request for examination was made
EP15843924

ENDOPROSTHESIS WITH PREDETERMINED CURVATURE FORMED BY TRI-TETHERS

IPC classification:
A61F 2/07
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
Request for examination was made
EP15771490

CATHETER SYSTEMS AND METHODS FOR RE-ENTRY IN BODY VESSELS WITH CHRONIC TOTAL OCCLUSION

IPC classification:
A61M 25/00, A61M 25/01, A61M 25/04, A61M 25/10
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
Request for examination was made
EP15845549

ISOXAZOLE DERIVATIVE AS MUTATED ISOCITRATE DEHYDROGENASE 1 INHIBITOR

IPC classification:
A61P 35/00, A61P 35/02, A61P 43/00, C07D 413/06, C07D 413/14, C07D 471/04, A61K 31/422, A61K 31/437, A61K 31/4439, A61K 31/454, A61K 31/496, A61K 31/5377
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Applicant:
National Cancer Center (Japan)
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
Request for examination was made
EP17160365

INHIBITORS OF FLAVIVIRIDAE VIRUSES

IPC classification:
A61P 31/00, C07D 409/12, A61K 31/381, A61K 31/4436
Applicant:
Gilead Sciences Inc
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
Request for examination was made
EP17155587

NUCLEOSIDE PHOSPHORAMIDATES

IPC classification:
C07H 19/20
Applicant:
Gilead Pharmasset LLC
Agent:
Sheila Jane Wallace, Marks & Clerk LLP
Status:
The application has been published

Please Sign in to use this feature